EDWARDS LIFESCIENCES CORP revenue breakdown overview

EDWARDS LIFESCIENCES CORP revenue for the last year amounted to 5.25 B EUR, the most of which — 3.97 B EUR — came from its highest performing source at the moment, Transcatheter Aortic Valve Replacement, the year earlier bringing 3.52 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought EDWARDS LIFESCIENCES CORP 3.10 B EUR, and the year before that — 3.18 B EUR.